Dr. Rose N. Eskin

Dr. Amanda Nickles Fader is a professor in the Johns Hopkins Hospital Department of Gynecology and Obstetrics and the Sidney Kimmel Cancer Center. She is the former fellowship director and division director of the Johns Hopkins Kelly Gynecologic Oncology Service and currently is Vice Chair of Gynecologic Surgical Operations and the Director of the Center for Rare Gynecologic Cancers. Additionally, she serves as the 2024-2025 President of the Society of Gynecologic Oncology. Dr. Fader received her undergraduate degree with highest distinction in music (violin performance) and pre-medicine from the University of Virginia. She earned her medical degree from the Medical College of Virginia, and completed her residency in obstetrics and gynecology at the Magee-Women’s Hospital of UPMC in Pittsburgh. Dr. Fader then underwent gynecologic oncology fellowship training at the Cleveland Clinic. She has co-authored more than 230 publications in peer-reviewed medical journals and is recognized as an expert in rare gynecologic tumors, clinical trials and quality and safety in surgery. She has a special interest in uterine serous carcinoma and low-grade serous carcinoma of the ovary and currently serves as the PI or co-PI of three international NRG Oncology clinical trials. Dr. Fader serves as a national board examiner in gynecologic oncology for the American Board of Obstetrics and Gynecology and Associate Editor of the Gynecologic Oncology journal is a member of the Rare Tumor and Uterine Corpus Committees of the NRG/Gynecologic Oncology Group. She is also co-founder of the Society of Gynecologic Oncology BRIDGES Program, a two-year longitudinal clinical trials and career development program for early-career oncologists. She has been the recipient of several research grants and awards for her research, including the Society of Gynecologic Oncology Innovations Award, the Best AAGL Paper in Minimally Invasive Gynecologic Oncology Surgery, a Department of Defense Ovarian Cancer Clinical Trials Academy Leadership Award, and National Cancer Institute Cervical SPORE grant. Dr. Fader is consistently recognized for clinical excellence on lists such as Baltimore magazine’s Top Docs and Castle Connolly’s Top Doctors, and is a recipient of the Top 10 Docs, Compassionate Doctors and Patient Choice Awards from Vitals.com. She has particular expertise with the surgical and medical management of uterine (endometrial), ovarian, cervical and vulvar cancers, as well as the treatment of women who are at high risk for developing a gynecologic malignancy. She has a special interest in caring for patients throughout the entire spectrum of their lives: from preventive oncology — minimizing key risk factors that can lead to gynecologic cancers — to survivorship initiatives addressing all aspects of recovery, including emotional well-being, sexual health and clinical follow-up. Dr. Fader is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ovarian Cancer, Bladder Reconstruction, and Hernia Surgery.

Dr. Purinton is a gynecologic oncologist, or a doctor who specializes in diagnosing and treating cancers that are located on women’s reproductive organs, like ovarian cancer. He serves as the chief of gynecologic oncology.|Dr. Purinton’s clinical interests include minimally invasive surgery, including robotic surgery techniques, which allow for quicker recovery time in the treatment of cancerous and noncancerous diseases of the female reproductive system; new chemotherapeutic protocols and targeted therapeutics in treating gynecologic cancers; ovarian cancer screening for early detection; improving quality of life for women with gynecologic cancers; and molecular profiling to lessen the chance of recurrence of gynecologic cancers.|Dr. Purinton earned his medical degree from the University of Miami School of Medicine. He completed his residency in obstetrics and gynecology at Johns Hopkins Hospital, and his fellowship in gynecologic oncology at University of Texas Southwestern Medical Center. Dr. Purinton also holds a doctor of philosophy degree in physiology. He is certified by the American Board of Obstetrics and Gynecology in general obstetrics and gynecology and in gynecologic oncology.|When he’s not at work, Dr. Purinton enjoys spending time with his wife and daughter at their home in Lewisburg.|Video: more from Dr. Scott Purinton, M.D., PhD. Dr. Purinton is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Cervical Cancer.

Bernice Robinson-Bennett is a Gynecologic Oncologist and an Oncologist in West Reading, Pennsylvania. Dr. Robinson-Bennett is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Cervical Cancer, and Bladder Reconstruction.